Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Deals
Lavamed Secures USD 40M in Angel and Series A Financing Rounds
January 29, 2025
Company
Drug
Innovent Biologics Doses First Volunteer in Orismilast Phase I Study
January 29, 2025
Company
Drug
Daiichi Sankyo Doses First Patient in Global Phase III TROPION-Lung08 Study
January 29, 2025
Company
Deals
Tsingke Biotech Secures RMB 400M Series B Financing for Expansion
January 29, 2025
Company
Deals
China Medical System Licenses Opzelura from Incyte for Greater China and Southeast Asia
January 29, 2025
Company
Deals
SAFE Raises RMB 500M in Series D Financing to Expand CRO Services
January 29, 2025
Company
Medical Device
Peijia Medical Enrolls First Patient in GeminiOne TEER System Study
January 29, 2025
Company
Drug
NMPA Approves Henlius’ HLX04 Biosimilar for Lung and Colorectal Cancer
January 29, 2025
Company
Deals
Yifan Pharma Transfers F-627 Distribution Rights in Germany to Apogepha
January 29, 2025
Company
Drug
Pyxis Oncology Receives FDA Approval for Biosion’s PYX-106 Clinical Trials
January 29, 2025
Company
Deals
Eli Lilly Ends License for Innovent’s Tyvyt Outside China
January 29, 2025
Company
Deals
Novartis Partners with Sinopharm for Commercial Promotion of Gleevec and Exjade in China
January 29, 2025
1
2
…
1,078
1,079
1,080
1,081
1,082
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?